| Kaylem Ephraim Arteaga, LCSW | |
|
1838 S 180 W, Orem, UT 84058-7476 | |
| (801) 602-4849 | |
| Not Available |
| Full Name | Kaylem Ephraim Arteaga |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 1838 S 180 W, Orem, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497385728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 9294757-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kaylem Ephraim Arteaga, LCSW 1838 S 180 W, Orem, UT 84058-7476 Ph: (801) 602-4849 | Kaylem Ephraim Arteaga, LCSW 1838 S 180 W, Orem, UT 84058-7476 Ph: (801) 602-4849 |
News Archive
In the final event leading to the development of Type 2 diabetes, the pancreas loses its ability to secrete insulin and clear glucose from the blood. Preventing this breakdown in insulin secretion is a key goal in the fight to reduce the burden of a disease that afflicts an estimated 29 million people in the United States.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Strategy-based cognitive training has the potential to enhance cognitive performance and spill over to real-life benefit according to a data-driven perspective article by the Center for BrainHealth at The University of Texas at Dallas published in the open-access journal Frontiers in Systems Neuroscience.
As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.
A chronic syndrome called vulvodynia that affects from four to seven percent of women is being studied by physicians at The Women's Health Institute at Robert Wood Johnson Medical School, part of Rutgers, The State University of New Jersey, in hopes of alleviating sometimes excruciating pain.
› Verified 2 days ago
Katie Fishman, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 600 S Geneva Rd, Orem, UT 84059 Phone: 801-877-5300 | |
Alicia Hills, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 202 E 800 S Ste 105, Orem, UT 84058 Phone: 385-283-1032 | |
Morgan Oliphant, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1255 N 1200 W, Orem, UT 84057 Phone: 801-229-1181 | |
Rebecca Jane Mcnairy, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1125 W Center St, Orem, UT 84057 Phone: 801-903-5903 | |
Erin Elizabeth Vasquez, LCSW, RPT Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1255 N 1200 W, Orem, UT 84057 Phone: 801-229-1181 Fax: 801-229-2787 | |
Mr. Mark James Capell, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 313 E 1200 S, Suite 104, Orem, UT 84058 Phone: 801-377-1595 Fax: 801-377-1598 | |
Terry R Routt, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 570 E 1400 S, Orem, UT 84097 Phone: 801-426-6661 Fax: 801-426-6660 |